Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: What should we choose when no HLA-matched related donor is available

Bone Marrow Transplantation

Volumn 48, Issue 11, 2013, Pages 1369-1376

  Nishiwaki, S ^a   Atsuta, Y ^a   Tanaka, J ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DRB1 ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE FREE SURVIVAL; DONOR SELECTION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HAPLOIDENTICAL RELATED DONOR; HLA MATCHING; HUMAN; LEUKEMIA RELAPSE; LIVING DONOR; MINIMAL RESIDUAL DISEASE; NONMYELOABLATIVE CONDITIONING; OVERALL SURVIVAL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; REVIEW; SURVIVAL RATE; UNRELATED DONORS;

ADULT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; UNRELATED DONORS;

EID: 84887221237     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.20     Document Type: Review

References (0)